top of page

Why are we still sick?

Why are we still sick?

Even in 2019, human life comes and goes largely as before. The maximum human lifespan hasn’t gone up significantly from all the cumulative innovations of the past decades. What has changed dramatically is child mortality and healthspan, i.e. the portion of your life that you live a “healthy” life. That’s a good thing. In exchange, we’ve managed to wreck ourselves trying to chase economic and technological progress. Job stress is estimated to cost American companies more than $300 billion a year in health costs, absenteeism, and poor performance. Regionally, a recent study showed that many Asian cities like Tokyo, Singapore, and Kuala Lumpur rank among the bottom in terms of overworking and work-life balance. Yikes.


Asia has some of the highest levels of stress, but not much infrastructure or culture in place to solve for it. The incentive structures aren’t in place in the same way in the developing world, and individuals must still bear the full weight of their healthcare. This is also an opportunity some disruptors are counting on, among them Discovery going global with their Vitality program and local player CXA.


One breakthrough of the last decade is that we now have data, thanks to wearables. The recent example of Fitbit teaming up with the Health Promotion Board in Singapore shows that we’re just at the beginning of leveraging these devices for the good of society, not just the individual. The challenge is going to be about utilizing all that data with ethics and privacy as priorities.


Total funding for APAC Healthtech continues trending up after a record 2018, but worryingly early-stage deals have been declining, with more investors hunting for fewer and bigger later-stage deals. This is a challenge for the 51% of Healthtech startups that are still pre Series A. There is an opportunity to follow Fintech in developing a healthy angel investor community to boost early-stage support.


To speed up innovation, major healthcare groups have followed banks in engaging the startup community directly through innovation labs. Two such programs were recently launched in Singapore, with likely many more to follow regionally.

At Healthzilla, we see great promise in the intersection of better data from wearables, more targeted research studies, and the predictive abilities of artificial intelligence. Not as replacements for clinical healthcare, but to empower individuals to take responsibility and control of their own preventative health journeys and accelerate data-driven innovation in preventative healthcare. Our free app is available to consumers worldwide, and we’ve recently made our fingertip stress scan, digital health check, and recovery analytics available as APIs to B2B partners such as healthcare & wellness providers, and insurance companies.

For more, visit



Bambi is one of our portfolio startups in Plug and Play APAC. As an in-house venture capital, our goal is to fund the teams that are building the defensible businesses of the future. By leveraging our capital, our network of VCs, and our corporate partners, we give our portfolio companies an added advantage. Join our platform today!

Click here to view the original source of the article.


Recent Posts


Meet Our Mentors: Alvin Edwald Chan, Behavioral Strategy Consultant

batchannouncements, malaysiaacceleratorprogram

Plug and Play announces 11 startups selected for the second batch of its Malaysia Accelerator program

Clicks® Among Startups Driving AI Innovation Selected To Join NVIDIA Inception Program

Want to receive the latest industry trends, news and event updates?
Want updates on the latest news and events from Plug and Play APAC?

Join our mailing list today!

APAC SUMMIT: 1 Day of Innovation, 50 Startups, 1 Platform

bottom of page